Recombinant Human CDC25B Protein，His

CDC25B is a member of the CDC25 phosphatase family, which plays a crucial role in the regulation of the cell cycle by activating cyclin-dependent kinases (CDKs). The enzyme functions primarily by dephosphorylating CDKs, thus promoting the transition from G2 phase to mitosis. Aberrant expression or activity of CDC25B has been implicated in various cancers, making it an important target for cancer research. Studies have shown that CDC25B is overexpressed in several tumor types, contributing to uncontrolled cell proliferation and tumor progression. The recombinant production of CDC25B protein has become a significant focus to understand its biochemical properties, regulatory mechanisms, and interactions with other cell cycle regulators. Such recombinant proteins can be utilized for structural studies, enzyme assays, and the development of small-molecule inhibitors targeting CDC25B. Additionally, understanding the mechanism of CDC25B not only aids in elucidating its role in cancer biology but also assists in the identification of potential therapeutic strategies for malignancies associated with its dysregulation. Overall, the exploration of CDC25B as a recombinant protein serves as a foundational step toward leveraging its biological significance in cancer treatment and cell cycle regulation studies.